Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens

By Yamamoto Satoko  

Breast Cancer, Vol. 20, Iss. 3, 2013-07 ,pp. : 262-270

Springer Publishing Company

Access to resources Recommend Favorite

Ki67 as a predictor of poor prognosis in patients with triplenegative breast cancer

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 149-152

Spandidos Publications

Access to resources Recommend Favorite

Serum folliclestimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in postmenopausal females with breast cancer

By            

Oncology Letters, Vol. 6, Iss. 4, 2013-01 ,pp. : 1128-1132

Spandidos Publications

Access to resources Recommend Favorite

Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer

By Delpech Y.  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 619-627

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients

By Bertucci F.   Finetti P.   Roche H.   Le Doussal J. M.   Marisa L.   Martin A. L.   Lacroix-Triki M.   Blanc-Fournier C.   Jacquemier J.   Peyro-Saint-Paul H.   Viens P.   Sotiriou C.   Birnbaum D.   Penault-Llorca F.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 625-632

Oxford University Press

Access to resources Recommend Favorite